UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2020-11, Vol.31 (11), p.1462-1475

2020

Volltextzugriff (PDF)

Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2021-04, Vol.32 (4), p.452-465

2021

Volltextzugriff (PDF)

Squamous cell carcinoma of the head and neck: EHNS–ESMO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2010-05, Vol.21 (suppl-5), p.v184-v186

2010

Volltextzugriff (PDF)

Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study

Annals of oncology, 2020-07, Vol.31 (7), p.942-950

2020

Volltextzugriff (PDF)

Preoperative chemotherapy in advanced resectable OCSCC: long-term results of a randomized phase III trial

Annals of oncology, 2014-02, Vol.25 (2), p.462-466

2014

Volltextzugriff (PDF)

Pain management in head and neck cancer patients undergoing chemo-radiotherapy: Clinical practical recommendations

Critical reviews in oncology/hematology, 2016-03, Vol.99, p.100-106

2016

Volltextzugriff (PDF)

Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial

European journal of cancer (1990), 2017-11, Vol.86, p.334-348

2017

Volltextzugriff (PDF)

SP-0613: Will personalised medicine approaches increase therapeutic options for salivary gland cancers?

Radiotherapy and oncology, 2014, Vol.111, p.S238-S238

Licitra, L

2014

Volltextzugriff (PDF)

Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma

Annals of oncology, 2017-11, Vol.28 (11), p.2813-2819

2017

Volltextzugriff (PDF)

Adjuvant androgen deprivation therapy for poor-risk, androgen receptor–positive salivary duct carcinoma

European journal of cancer (1990), 2019-03, Vol.110, p.62-70

2019

Volltextzugriff (PDF)

SP-011: Targeted Agents: Cetuximab and Beyond

Radiotherapy and oncology, 2013-02, Vol.106, p.S4-S4

Licitra, L

2013

Volltextzugriff (PDF)

Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial

Annals of oncology, 2014-04, Vol.25 (4), p.801-807

2014

Volltextzugriff (PDF)

Management of tyrosine kinase inhibitors (TKI) side effects in differentiated and medullary thyroid cancer patients

Baillière's best practice & research. Clinical endocrinology & metabolism, 2017-06, Vol.31 (3), p.349-361

2017

Volltextzugriff (PDF)

‘Rare cancers’: not all together in clinical studies

Annals of oncology, 2022-05, Vol.33 (5), p.463-465

2022

Volltextzugriff (PDF)

Phase 3 Randomized Trial on Larynx Preservation Comparing Sequential vs Alternating Chemotherapy and Radiotherapy

JNCI : Journal of the National Cancer Institute, 2009-02, Vol.101 (3), p.142-152

2009

Volltextzugriff (PDF)

Nasopharyngeal cancer: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2012-10, Vol.23 Suppl 7, p.vii83-vii85

2012

Volltextzugriff (PDF)

SP-0587 BIOLOGY AND TARGETING OF HPV

Radiotherapy and oncology, 2012-05, Vol.103, p.S234-S234

Licitra, L

2012

Volltextzugriff (PDF)

Squamous cell carcinoma of the head and neck: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Annals of oncology, 2009-05, Vol.20 (suppl-4), p.iv121-iv122

2009

Volltextzugriff (PDF)

Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer

Annals of oncology, 2017-10, Vol.28 (10), p.2526-2532

2017

Volltextzugriff (PDF)

Personalized biomarker-based treatment strategy for patients with squamous cell carcinoma of the head and neck: EORTC position and approach

Annals of oncology, 2018-12, Vol.29 (12), p.2313-2327

2018

Volltextzugriff (PDF)

A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

Annals of oncology, 2017-11, Vol.28 (11), p.2820-2826

2017

Volltextzugriff (PDF)

Long-term update of the 24954 EORTC phase III trial on larynx preservation

European journal of cancer (1990), 2016-09, Vol.65, p.109-112

2016

Volltextzugriff (PDF)

Comprehensive gene expression meta-analysis of head and neck squamous cell carcinoma microarray data defines a robust survival predictor

Annals of oncology, 2014-08, Vol.25 (8), p.1628-1635

2014

Volltextzugriff (PDF)

Reprint of “Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up”

Oral oncology, 2021-02, Vol.113, p.105042-105042, Article 105042

2021

Volltextzugriff (PDF)

Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study

Annals of oncology, 2011-05, Vol.22 (5), p.1078-1087

2011

Volltextzugriff (PDF)

1 – 25 von 565

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(518)
Mit Volltextzugriff
(521)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(223)
Life Sciences & Biomedicine
(187)
Humans
(179)
Oncology
(139)
Female
(101)
Male
(100)
Biological And Medical Sciences
(87)
Middle Aged
(86)
Aged
(83)
Medical Sciences
(80)
Adult
(79)
Hematology, Oncology And Palliative Medicine
(71)
Tumors
(71)
Pharmacology. Drug Treatments
(41)
Technology
(37)
Treatment Outcome
(36)
Otorhinolaryngology. Stomatology
(33)
Chemotherapy
(29)
Aged, 80 And Over
(28)
Antineoplastic Agents
(28)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

Squamous cell carcinoma of the head and neck: EHNS–ESMO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study

Preoperative chemotherapy in advanced resectable OCSCC: long-term results of a randomized phase III trial

Pain management in head and neck cancer patients undergoing chemo-radiotherapy: Clinical practical recommendations

Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial

SP-0613: Will personalised medicine approaches increase therapeutic options for salivary gland cancers?

Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma

Adjuvant androgen deprivation therapy for poor-risk, androgen receptor–positive salivary duct carcinoma

SP-011: Targeted Agents: Cetuximab and Beyond

Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial

Management of tyrosine kinase inhibitors (TKI) side effects in differentiated and medullary thyroid cancer patients

‘Rare cancers’: not all together in clinical studies

Phase 3 Randomized Trial on Larynx Preservation Comparing Sequential vs Alternating Chemotherapy and Radiotherapy

Nasopharyngeal cancer: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up

SP-0587 BIOLOGY AND TARGETING OF HPV

Squamous cell carcinoma of the head and neck: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer

Personalized biomarker-based treatment strategy for patients with squamous cell carcinoma of the head and neck: EORTC position and approach

A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

Long-term update of the 24954 EORTC phase III trial on larynx preservation

Comprehensive gene expression meta-analysis of head and neck squamous cell carcinoma microarray data defines a robust survival predictor

Reprint of “Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up”

Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study

Suchergebnisse filtern